Literature DB >> 8240248

Dissociation, unfolding and refolding trials of pig kidney 3,4-dihydroxyphenylalanine (dopa) decarboxylase.

P Dominici1, P S Moore, C Borri Voltattorni.   

Abstract

The effect of guanidinium chloride (GuCl) on enzyme activity, hydrodynamic volume, circular dichroism, and fluorescence of 3,4-dihydroxyphenylalanine (Dopa) decarboxylase from pig kidney (pkDDC) was studied under equilibrium conditions. Unfolding proceeds in at least three stages. The first transition, occurring between 0 and 1 M GuCl, gives rise to a dimeric inactive species which has lost pyridoxal 5'-phosphate (PLP), and has a high tendency to aggregate, but retains almost all of the native spectroscopic characteristics. The second equilibrium transition, between 1 and 2.2 M GuCl, involves dimer dissociation, with some loss of tertiary and secondary structure. Additionally, gross conformational changes at or near the PLP microenvironment were detected by fluorescence of NaBH4-reduced enzyme. The third step, presumably representing complete unfolding of pkDDC, appears to be complete at 4.5 M GuCl, as indicated by the lack of further substantial changes in any of the signals being studied. Attempts at refolding resulted in the findings that: (1) partial reactivation is observed only starting from enzyme denatured at concentrations below 1.5 M GuCl, and (2) starting from completely denatured protein, the refolding process is apparently reversible down to concentrations of approx. 2 M GuCl. Taken together, this would seem to indicate that the monomer-dimer transition is impaired under the experimental conditions tested. A plausible model is presented for the unfolding/refolding of pkDDC.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8240248      PMCID: PMC1134907          DOI: 10.1042/bj2950493

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  29 in total

1.  Denaturation of glucose-6-phosphate dehydrogenase from Leuconostoc mesenteroides by guanidine hydrochloride; identification of inactive, partially unfolded, dimeric intermediates.

Authors:  J J Plomer; A Gafni
Journal:  Biochim Biophys Acta       Date:  1992-08-21

2.  The unfolding and refolding of pig heart fumarase.

Authors:  S M Kelly; N C Price
Journal:  Biochem J       Date:  1991-05-01       Impact factor: 3.857

3.  The unfolding and attempted refolding of mitochondrial aspartate aminotransferase from pig heart.

Authors:  S M West; N C Price
Journal:  Biochem J       Date:  1990-01-01       Impact factor: 3.857

4.  An investigation of the assay of dopamine using trinitrobenzensulphonic acid.

Authors:  A Charteris; R John
Journal:  Anal Biochem       Date:  1975-06       Impact factor: 3.365

5.  Reversible dissociation and unfolding of aspartate aminotransferase from Escherichia coli: characterization of a monomeric intermediate.

Authors:  M Herold; K Kirschner
Journal:  Biochemistry       Date:  1990-02-20       Impact factor: 3.162

6.  Refolding and association of oligomeric proteins.

Authors:  R Jaenicke; R Rudolph
Journal:  Methods Enzymol       Date:  1986       Impact factor: 1.600

7.  Comparison of the rates of inactivation and conformational changes of creatine kinase during urea denaturation.

Authors:  Q Z Yao; M Tian; C L Tsou
Journal:  Biochemistry       Date:  1984-06-05       Impact factor: 3.162

8.  Affinity labeling of pig kidney 3,4-dihydroxyphenylalanine (Dopa) decarboxylase with N-(bromoacetyl)pyridoxamine 5'-phosphate. Modification of an active-site cysteine.

Authors:  P Dominici; B Maras; G Mei; C Borri Voltattorni
Journal:  Eur J Biochem       Date:  1991-10-15

9.  Dissociation and aggregation of D-glyceraldehyde-3-phosphate dehydrogenase during denaturation by guanidine hydrochloride.

Authors:  S J Liang; Y Z Lin; J M Zhou; C L Tsou; P Q Wu; Z K Zhou
Journal:  Biochim Biophys Acta       Date:  1990-04-19

10.  Denaturation-renaturation of the fibrin-stabilizing factor XIII a-chain isolated from human placenta. Properties of the native and reconstituted protein.

Authors:  U Rinas; B Risse; R Jaenicke; K J Abel; G Zettlmeissl
Journal:  Biol Chem Hoppe Seyler       Date:  1990-01
View more
  8 in total

1.  Cloning and expression of pig kidney dopa decarboxylase: comparison of the naturally occurring and recombinant enzymes.

Authors:  P S Moore; P Dominici; C Borri Voltattorni
Journal:  Biochem J       Date:  1996-04-01       Impact factor: 3.857

2.  Mutation of cysteine 111 in Dopa decarboxylase leads to active site perturbation.

Authors:  P Dominici; P S Moore; S Castellani; M Bertoldi; C B Voltattorni
Journal:  Protein Sci       Date:  1997-09       Impact factor: 6.725

3.  Dopa decarboxylase exhibits low pH half-transaminase and high pH oxidative deaminase activities toward serotonin (5-hydroxytryptamine).

Authors:  M Bertoldi; C B Voltattorni
Journal:  Protein Sci       Date:  2001-06       Impact factor: 6.725

4.  Folding pathway of the pyridoxal 5'-phosphate C-S lyase MalY from Escherichia coli.

Authors:  Mariarita Bertoldi; Barbara Cellini; Douglas V Laurents; Carla Borri Voltattorni
Journal:  Biochem J       Date:  2005-08-01       Impact factor: 3.857

5.  Molecular insights into the pathogenicity of variants associated with the aromatic amino acid decarboxylase deficiency.

Authors:  Riccardo Montioli; Barbara Cellini; Carla Borri Voltattorni
Journal:  J Inherit Metab Dis       Date:  2011-05-04       Impact factor: 4.982

6.  Reaction of dopa decarboxylase with L-aromatic amino acids under aerobic and anaerobic conditions.

Authors:  M Bertoldi; C Borri Voltattorni
Journal:  Biochem J       Date:  2000-12-01       Impact factor: 3.857

7.  In vivo and in vitro examination of stability of primary hyperoxaluria-associated human alanine:glyoxylate aminotransferase.

Authors:  Erin D Hopper; Adrianne M C Pittman; Michael C Fitzgerald; Chandra L Tucker
Journal:  J Biol Chem       Date:  2008-09-09       Impact factor: 5.157

8.  Identification by virtual screening and in vitro testing of human DOPA decarboxylase inhibitors.

Authors:  Frederick Daidone; Riccardo Montioli; Alessandro Paiardini; Barbara Cellini; Antonio Macchiarulo; Giorgio Giardina; Francesco Bossa; Carla Borri Voltattorni
Journal:  PLoS One       Date:  2012-02-23       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.